In 1919, a young English-born pharmacist, Fredrick Alfred Upsher Smith, created Upsher-Smith, a company where he envisioned honesty and ethics as its driving force along with a constant focus on the welfare of patients and customers. With these guiding principles, Upsher-Smith quickly developed a reputation for excellence by perfecting the refinement of digitalis from the foxglove plant and producing it in a standardized potency with consistency in dosage from one batch to the next, an advancement never before achieved in the 134 years since the drug’s discovery.
“As we reflect on the people, products and innovation that drove a period of rapid growth for Upsher-Smith over the last century, we are reminded that our steadfast commitment to improving the health and lives of patients through high-quality products and sustainable growth will drive us into our second century,” said Rusty Field, president and chief executive officer of Upsher-Smith.
Upsher-Smith will begin the new century with its most aggressive new product growth plan in its history. The company plans to diversify and expand its portfolio of products while forging new partnerships that drive future innovation and growth.